BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Drug Development

  Key Milestone Reached In Catalyst Biosciences’s Subcutaneous Factor IX Program

  April 11, 2017

   · 

  4 min read
• Business

  MonoSolRx LLC Appoints James S. Scibetta To Board Of Directors

  April 11, 2017

   · 

  3 min read
• Business

  Dr. Lorianne K. Masuoka Joins Marinus Pharma As Chief Medical Officer

  April 11, 2017

   · 

  4 min read
• Policy

  Agile Therapeutics, Inc. Announces Results Of Its Pre-Submission Meeting With FDA

  April 11, 2017

   · 

  4 min read
• Drug Development

  Nabriva Announces Enrollment Completion For LEAP 1, A Phase III Clinical Trial Evaluating Lefamulin In Community-Acquired Bacterial Pneumonia

  April 11, 2017

   · 

  7 min read
• Business

  aTyr Pharma Announces Appointment Of Timothy P. Coughlin To Its Board Of Directors

  April 11, 2017

   · 

  4 min read
• Business

  Cellectar Biosciences Adds Industry Veterans Douglas Swirsky And Frederick Driscoll To Its Board Of Directors

  April 11, 2017

   · 

  4 min read
• Lone Star Bio

  Texas A&M University Research Points To Potential Way To Prevent Seizure-Caused Brain Damage

  April 11, 2017

   · 

  3 min read
• Drug Development

  Five Prime Announces Completion Of Enrollment For The Phase II Part Of The Ongoing Trial Of Cabiralizumab For The Treatment Of Pigmented Villonodular Synovitis (PVNS)

  April 11, 2017

   · 

  3 min read
• Business

  Caladrius Biosciences To Hold 2017 Annual Stockholder Meeting On May 16

  April 11, 2017

   · 

  1 min read